Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#494 most reported symptom for this vaccine
Gastrointestinal disorder has been reported 36 times in association with Tdap (Boostrix) vaccination in VAERS. This represents 0.1% of all 52,846 reports for this vaccine.
Among these reports, 1 mentioned death (2.78%) and 8 involved hospitalization (22.2%).
Gastrointestinal disorder is the #494 most frequently reported symptom for Tdap (Boostrix) out of 2243 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 36 reports of Gastrointestinal disorder after Tdap (Boostrix) vaccination may seem alarming, but context is critical.
The mortality rate of 2.78% warrants monitoring, though VAERS deaths represent temporal associations, not confirmed causal links.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.